Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography

Laurence Gabriel

Status: Completed

Conditions: Left Ventricular Hypertrophy

Study type: Observational

Funder types: Other

Identifiers

NCT02221141

Fabry Disease Cardioscreening

Details and patient eligibility

About

The purpose of this study is to determine the prevalence in Belgium of Fabry disease in patients with unexplained hypertrophic cardiomyopathy measured by echocardiography and to determine in Fabry patients which was the most frequently initial symptom.

Actually the early diagnosis is important because a treatment exists that can prevent future complications.

Enrollment: 120 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• unexplained left ventricular hypertrophy

Exclusion criteria

• isolated septal hypertrophy